The mass rollout of weight loss injections on the NHS in England began in June. It means GPs are allowed to prescribe the ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

The evolution of controversial new weight loss drugs is shining a spotlight on a crippling, little-understood food phenomenon ...

Weight loss drugs are being hailed as revolutionary tools in the fight against obesity. Originally developed for diabetes, these drugs have gone mainstream - recommended by doctors, and sought after ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...